Skip to content

Medical-device intelligence

KLN: Radioimmunoassay, Cocaine Metabolite

FDA product code KLN: Radioimmunoassay, Cocaine Metabolite. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
KLN
FDA device name
Radioimmunoassay, Cocaine Metabolite
Device class
2
Regulation number
862.3250
Medical specialty
Clinical Toxicology
Review panel
TX

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore clinical toxicology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

14 clearance records and 0 recall records in the covered releases, across 7 source company names and 1 product codes. Dated history runs from Mar 24, 1983 to Nov 6, 2001.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
KLN · Radioimmunoassay, Cocaine Metabolite140

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

14 matching records
Device / recordCompany in FDA recordSourceSource date
PSYCHEMEDICS RIA COCAINE ASSAYK010868 · KLNPsychemedics Corp.510(k)Nov 6, 2001FDA decision date
URINE COCAINE METABOLITE DIRECT RIA KIT (I-125)K913867 · KLNImmunalysis Corporation510(k)Sep 19, 1991FDA decision date
ABUSCREEN(R) RADIOIMMUN FOR COCAINE METABOLITEK913722 · KLNRoche Diagnostic Systems, Inc.510(k)Sep 10, 1991FDA decision date
ABUSCREEN RADIOIMMUNOASSAY FOR COCAINE METABOLITEK912756 · KLNRoche Diagnostic Systems, Inc.510(k)Jul 26, 1991FDA decision date
TARGET COCAINE METABOLITE-RK910122 · KLNV-Tech, Inc.510(k)Mar 19, 1991FDA decision date
TARGET COCAINE METABOLITE-VK910123 · KLNV-Tech, Inc.510(k)Mar 19, 1991FDA decision date
MILENIA COCAINE METABOLITEK910044 · KLNDiagnostic Products Corp.510(k)Feb 13, 1991FDA decision date
ABUSCREEN ONTRAK FOR COCAINE (200NG/ML)K905730 · KLNRoche Diagnostic Systems, Inc.510(k)Jan 15, 1991FDA decision date
ABUSCREEN ONLINE TM FOR COCAINE METABOLITEK904995 · KLNRoche Diagnostic Systems, Inc.510(k)Nov 28, 1990FDA decision date
MICROMEDIC CRACKPOT RIA KITK880674 · KLNIcn Micromedic Systems510(k)Oct 6, 1988FDA decision date
RESUB. URINE COCAINE META. DIRECT RIA KIT [I-125]K871549 · KLNImmunalysis Corporation510(k)Jun 16, 1987FDA decision date
COAT-A-COUNT COCAINE METABOLITE TKCN1 & TKCN5K870740 · KLNDiagnostic Products Corp.510(k)Mar 19, 1987FDA decision date
DOUBLE ANTIBODY COCAINE METABOLITE RIA KITK862218 · KLNDiagnostic Products Corp.510(k)Jun 27, 1986FDA decision date
ABUSCREEN RADIOIMMUNOASSAY-COCAINE METAK830480 · KLNHoffmann-La Roche, Inc.510(k)Mar 24, 1983FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗